U.S. July CPI aligns with market expectations, causing the USD-KRW exchange rate to drop to the low 1,410s in Seoul's forex market.

SK Biopharm's U.S. trials of epilepsy drug candidate opicopalim have been partially placed on hold by the FDA, temporarily stopping new enrollment while existing patients continue treatment.

AI growth and U.S. trade policies reshape South Korea's manufacturing, boosting Chinese car imports and shifting semiconductor exports to Taiwan.